Patients suffering from an inherited form of blindness have, for the first time, had their vision dramatically improved by gene therapy.
The first six people given experimental injections at the Oxford Eye Hospital were able to see better.
Researchers at the city's university and also at Southampton University say trials have shown promising results for the treatment of Choroideremia.
The Phase I clinical trial is funded by the Health Innovation Challenge Fund, a partnership between the Wellcome Trust and the Department of Health.
More top news
Apple growers warn curbing immigration could be 'disaster' for industry
The decision to leave the EU could have a profound effect on millions of children who weren't able to vote. So what do they think?
Monday Evening's Pollen Forecast